| 产品描述: | SMIP004 is a SKP2 E3 ligase inhibitor, which downregulates SKP2 and to stabilise p27. SMIP004 is a cancer cell selective apoptosis inducer of human prostate cancer cells |
| 靶点: |
SKP2 E3 ligase;Apoptosis; Others; E1/E2/E3Enzyme |
| 体内研究: |
SMIP004 potently inhibits the growth of prostate and breast cancer xenografts in SCID mice |
| 参考文献: |
1. Li C, et al. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J Exp Clin Cancer Res. 2019 Feb 13;38(1):76. 2. Rico-Bautista E, Zhu W, Kitada S, Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via UPR Signaling. Oncotarget. 2013 Jul 14. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
4.871 ml |
24.355 ml |
48.709 ml |
| 5 mM |
0.974 ml |
4.871 ml |
9.742 ml |
| 10 mM |
0.487 ml |
2.435 ml |
4.871 ml |
| 50 mM |
0.097 ml |
0.487 ml |
0.974 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |